EP3125893
DEUTERATED HETEROCYCLE FUSED GAMMA-CARBOLINES AS ANTAGONISTS OF 5-HT2A RECEPTORS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
3.4.2015EP published:
20.9.2023EP application number:
15773589.5
EPO information:
European Patent Register
Max expiry date:
2.4.2035
Title in English:
DEUTERATED HETEROCYCLE FUSED GAMMA-CARBOLINES AS ANTAGONISTS OF 5-HT2A RECEPTORSLanguage of the patent:
English
Timeline
Today
3.4.2015EP application
20.9.2023EP Publication
Owner
Name:
Intra-Cellular Therapies, Inc.Address:
430 East 29th Street, Suite 900, New York, NY 10016, US
Inventor
Name:
MATES, SharonAddress:
New York, New York 10016, US
Name:
LI, PengAddress:
New York, New York 10016, US
Name:
WENNOGLE, Lawrence P.Address:
New York, New York 10016, US
Name:
DAVIS, RobertAddress:
New York, New York 10016, US
Priority
Number:
201461975610 PDate:
4.4.2014Country:
US
Classification
Categories:
A61K 31/4985, C07D 471/14, A61K 45/06, C07D 471/16, A61P 25/00, C07B 59/00, A61P 1/00, A61P 3/04, A61P 21/02, A61P 25/04, A61P 25/14, A61P 25/16, A61P 25/18, A61P 25/20, A61P 25/22, A61P 25/24, A61P 29/02, A61P 43/00, A61P 25/28